Back
PTC Therapeutics Stock Price Chart
Sponsored
PTCT
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
PTCT
PTC Therapeutics
Last Price:
36.63
Seasonality Move:
3.17%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight buying pressure.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.51 | Buy |
20-day SMA: | 33.98 | Buy |
50-day SMA: | 33.37 | Buy |
200-day SMA: | 30.81 | Buy |
8-day EMA: | 34.92 | Buy |
20-day EMA: | 34.06 | Buy |
50-day EMA: | 33.59 | Buy |
200-day EMA: | 32.44 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.58 | Buy |
Relative Strength Index (14 RSI): | 66.8 | Buy |
Chaikin Money Flow: | 417006 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.5 - 35.44) | Buy |
Bollinger Bands (100): | (31.79 - 36.13) | Buy |
PTC Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 36.64 while PTCT 8-day simple moving average is 34.51, which is a Buy signal.
- The stock price of PTCT is 36.64 while PTC Therapeutics 20-day SMA is 33.98, which makes it a Buy.
- PTC Therapeutics 50-day simple moving average is 33.37 while PTCT share price is 36.64, making it a Buy technically.
- PTCT stock price is 36.64 and PTC Therapeutics 200-day simple moving average is 30.81, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
43
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Sell
The current PTC Therapeutics [PTCT] share price is $36.64. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
2.82B
Price in USD:
36.64
Share Volume:
906.23K
PTC Therapeutics 52-Week Range
52-Week High:
40.69
52-Week Low:
17.53
Sell
43
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?
The PTC Therapeutics stock price is 36.64 USD today. -
Will PTCT stock go up or go down?
PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is PTC Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 36.64 while PTCT 8-day exponential moving average is 34.92, which is a Buy signal.
- The stock price of PTCT is 36.64 while PTC Therapeutics 20-day EMA is 34.06, which makes it a Buy.
- PTC Therapeutics 50-day exponential moving average is 33.59 while PTCT share price is 36.64, making it a Buy technically.
- PTCT stock price is 36.64 and PTC Therapeutics 200-day simple moving average is 32.44, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
- PTCT Moving Average Covergence Divergence (MACD) indicator is 0.58, suggesting PTC Therapeutics is a Buy
- PTC Therapeutics Relative Strength Index (RSI) is 66.8, which suggest PTC Therapeutics is overbought
- The Bollinger Bands (25) for PTC Therapeutics is (32.5 - 35.44), which suggest PTC Therapeutics is a Buy
- The Bollinger Bands (100) for PTC Therapeutics is (31.79 - 36.13), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.